NIH-funded research R01 grant

How HIV and cocaine use affect the blood-brain barrier

Official title: Immune mechanisms that shape the blood brain barrier in people living with HIV and cocaine use disorder

Funded at Johns Hopkins University · NIH-11096032 · Data updated 2026-11-12

This study is looking at how using cocaine might affect the brain's protective barrier in people living with HIV, and how this could impact their thinking and memory.

More Cocaine Use Disorder research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJune 1, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$1,039,343
NIH project number5R01DA060568-02
Project IDNIH-11096032 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who have a history of cocaine use disorder.

Less likely to help

Patients who do not have HIV or a history of cocaine use disorder may not benefit from this research.

What this research studies

This research investigates the impact of HIV and cocaine use on the blood-brain barrier (BBB), which protects the brain from harmful substances. It aims to understand how cocaine misuse can lead to BBB impairment in individuals living with HIV, potentially affecting their cognitive functions. The study will analyze the mechanisms by which HIV-infected immune cells and cocaine influence BBB integrity and the implications for brain health. By examining specific immune cell types and their behavior, the research seeks to uncover the links between substance use and neurological complications in this population.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for cognitive impairments in people living with HIV who also struggle with cocaine use disorder.

How similar studies have gone: Previous research has shown that understanding the interactions between substance use and immune responses can lead to significant advancements in treating related neurological conditions.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Veenhuis, Rebecca Terilli — Johns Hopkins University
  • Study coordinator: Veenhuis, Rebecca Terilli

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.